In Brief Gulden Mesara named chief communications and marketing officer at City of Hope September 04, 2020Vol.46 No.33
Mojo Sharpless, “world’s smartest dog,” shows off her talent to kids at NCI’s Camp Fantastic September 04, 2020Vol.46 No.33By Alexandria Carolan
Sharpless lays out a scenario for achieving 15% payline for RPGsNCAB approves ad hoc group to review TMIST, other detection trials impacted by COVID September 04, 2020Vol.46 No.33By Alexandria Carolan and Paul Goldberg
Drugs & Targets FDA accepts Karyopharm’s sNDA for Xpovio as a treatment for multiple myeloma after at least one prior line of therapy July 24, 2020Vol.46 No.30
Drugs & Targets FDA issues draft guidance to encourage cannabis-related clinical research July 24, 2020Vol.46 No.30
Drugs & Targets FDA proposes rule on reporting requirement under Right to Try Act July 24, 2020Vol.46 No.30
Clinical Roundup UArizona Health Sciences’ portable device may change standard of care for skin cancer July 24, 2020Vol.46 No.30
Clinical Roundup American College of Surgeons introduces Cancer Surgery Standards Program July 24, 2020Vol.46 No.30
Trials & Tribulations Assessing the impact of the CMS price transparency rule on patients with prostate cancer July 24, 2020Vol.46 No.30By Ankit Agarwal and Trevor J. Royce
